Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FENNEC PHARMACEUTICALS INC.

(FENC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Fennec Pharmaceuticals : Earnings Flash (FRX.TO) FENNEC PHARMACEUTICALS Posts Net loss for Q2 was US$4.0 million ($0.15 per share), compared to $4.8 million ($0.21 per share) for the same period in 202

08/10/2021 | 06:03am EDT


© MT Newswires 2021
All news about FENNEC PHARMACEUTICALS INC.
09/09FENNEC PHARMACEUTICALS : to Participate in Upcoming Investor Conferences
AQ
08/10FENNEC PHARMACEUTICALS : Wedbush Lifts Price Target for Fennec Pharmaceuticals to $12 From..
MT
08/10FENNEC PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and R..
AQ
08/10FENNEC PHARMACEUTICALS : Reports Q2 Net loss of US$0.15 Per Share; Provides Business Updat..
MT
08/10FENNEC PHARMACEUTICALS : Earnings Flash (FRX.TO) FENNEC PHARMACEUTICALS Posts Net loss for..
MT
08/10FENNEC PHARMACEUTICALS : Earnings Flash (FRX.TO) FENNEC PHARMACEUTICALS Posts Net loss for..
MT
08/10Fennec Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Bus..
GL
08/06NORTH AMERICAN MORNING BRIEFING : Stock Futures -2-
DJ
06/30FENNEC PHARMACEUTICALS INC. : Submission of Matters to a Vote of Security Holders (form 8-..
AQ
06/29Fennec Announces Results of Annual Meeting
GL
More news
Analyst Recommendations on FENNEC PHARMACEUTICALS INC.
More recommendations
Financials (USD)
Sales 2021 21,0 M - -
Net income 2021 -17,4 M - -
Net Debt 2021 - - -
P/E ratio 2021 -13,2x
Yield 2021 -
Capitalization 228 M 228 M -
Capi. / Sales 2021 10,8x
Capi. / Sales 2022 11,3x
Nbr of Employees 9
Free-Float 83,1%
Chart FENNEC PHARMACEUTICALS INC.
Duration : Period :
Fennec Pharmaceuticals Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FENNEC PHARMACEUTICALS INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 8,76 $
Average target price 13,60 $
Spread / Average Target 55,3%
EPS Revisions
Managers and Directors
Rostislav C. Raykov Chief Executive Officer & Director
Robert C. Andrade Chief Financial Officer
Khalid Islam Chairman
Chris A. Rallis Independent Director
Adrian James Haigh Independent Director
Sector and Competitors
1st jan.Capi. (M$)
FENNEC PHARMACEUTICALS INC.17.58%228
GILEAD SCIENCES, INC.15.41%83 993
BIONTECH SE241.44%69 162
WUXI APPTEC CO., LTD.24.51%65 142
REGENERON PHARMACEUTICALS18.47%59 196
VERTEX PHARMACEUTICALS-22.35%48 536